Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-19-005115
Filing Date
2019-04-10
Accepted
2019-04-10 16:06:22
Documents
3
Effectiveness Date
2019-04-10

Document Format Files

Seq Description Document Type Size
1 defa14a.htm DEFA14A 29370
2 image_001.jpg GRAPHIC 140284
3 image_002.jpg GRAPHIC 164295
  Complete submission text file 0001493152-19-005115.txt   450060
Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

EIN.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37348 | Film No.: 19741743
SIC: 2834 Pharmaceutical Preparations